TAMOXIFEN AND BENIGN ENDOMETRIAL LESIONS

Citation
X. Demuylder et al., TAMOXIFEN AND BENIGN ENDOMETRIAL LESIONS, European journal of cancer, 34, 1998, pp. 18-19
Citations number
9
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
34
Year of publication
1998
Supplement
4
Pages
18 - 19
Database
ISI
SICI code
0959-8049(1998)34:<18:TABEL>2.0.ZU;2-U
Abstract
Benign endometrial lesions are common among breast cancer patients tre ated with tamoxifen but also among healthy women taking this drug in a breast cancer prevention trial. The most frequent; lesion is glandulo cystic atrophy which seems specific for this drug. Endometrial polyps are also very often seen but only a few of them could undergo malignan t degeneration. Hyperplasia of the endometrium is more frequently repo rted among tamoxifen patients than among control patients. (C) 1998 El sevier Science Ltd. All rights reserved.